EDEG 2021 - PROGRAMME

zoom

Final Program

Central European Summer Time (CEST)


Monday 26th April 2021

09:00 – 09.10 Opening/Introduction – MATTHIAS SCHULZE (CHAIR EDEG)

09:10 - 10:10 Oral Presentations Session 1 - Mechanistic basis for DM and its complications

CHAIRS: STAVROS LIATIS, ANNA BIRUKOV

OP1 ---WITHDRAWN

OP2 - THE GUT MICROBIOME AND DIABETES STATUS IN THE MULTIETHNIC COHORT
Gertraud Maskarinec, University of Hawaii, Honolulu, HI

OP3 - WEIGHT CHANGES IN TYPE 2 DIABETES AND CANCER RISK: A LATENT CLASS TRAJECTORY MODEL STUDY
Britt W Jensen, Center for Clinical Research and Prevention, Bispebjerg and Frederiksberg Hospital, Copenhagen, Denmark

OP4 - MACHINE LEARNING FOR DIABETES SURVEILLANCE : THE TYPE 1/TYPE 2 CLASSIFICATION ALGORITHM AND ITS APPLICATION TO THE FRENCH NATIONAL HEALTHCARE DATA SYSTEM
Sonsoles Fuentes,Santé Publique France, Saint Maurice, France

OP5 - NATRIURETIC PEPTIDES AND TYPE 2 DIABETES
Chaterina Sujana,Helmholtz-Zentrum München, Neuherberg, Germany

OP6 - REDUCED AUTONOMIC NERVOUS FUNCTION DOES NOT DECREASE ESTIMATED GLOMERULAR FILTRATION RATE IN A GENERAL POPULATION: THE WHITEHALL II STUDY
Martin S. Christensen, Aarhus University, Aarhus, Denmark

10:10 - 10:15 5-min virtual exercise

10:15 - 11:05 Oral Presentations Session 2 - Diet and Lifestyle Factors in Diabetes

CHAIRS: MATTHIAS SCHULZE, NICOLETTE DEN BRAVER

OP7 - TOBACCO USE AND INTERACTION WITH GENOTYPES OF HUMAN LEUKOCYTE ANTIGEN IN THE RISK OF LATENT AUTOIMMUNE DIABETES IN ADULTS: RESULTS FROM TWO POPULATION-BASED STUDIES
Jessica Edstorp, Karolinska Institutet, Stockholm, Sweden

OP8 - ASSOCIATIONS OF ULTRA-PROCESSED FOOD AND ITS UNDERLYING CONSUMPTION PATTERNS WITH INCIDENT TYPE 2 DIABETES: THE LIFELINES COHORT STUDY
Mingjie Duan, University of Groningen, University Medical Center Groningen, Department of Internal Medicine, Division Nephrology Groningen, The Netherlands

OP9 - LIFESTYLE BEHAVIOR PATTERNS AND INCIDENT TYPE 2 DIABETES IN THE LIFELINES COHORT STUDY
Mingjie Duan, University of Groningen, University Medical Center Groningen, Department of Internal Medicine, Groningen, The Netherlands

OP10 - REDUCED RANK REGRESSION-DERIVED DIETARY PATTERNS RELATED WITH FATTY LIVER INDEX AND ASSOCIATIONS WITH TYPE 2 DIABETES MELLITUS AMONG GHANAIAN POPULATIONS UNDER TRANSITION: THE RODAM STUDY
Tracy B Osei, Heidelberg Institute of Global Health (HIGH), Universitaetsklinikum Heidelberg, Germany

OP11 - ASSOCIATION OF THE ODD-CHAIN FATTY ACIDS IN SPECIFIC LIPID CLASSES WITH TYPE 2 DIABETES RISK AND DIETARY VARIABLES IN THE EPIC-POTSDAM COHORT
Marcela Prada, Department of Molecular Epidemiology, German Institute of Human Nutrition Potsdam-Rehbrücke, Nuthetal, Germany

11:05 - 11:30 25 min break

11:30 - 12:00 Plenary session 1 - Covid 19 & Diabetes

CHAIR: STAVROS LIATIS

Samy Hadjadj
Professor of Endocrinology and Diabetes, Faculty of Medicine and Pharmacy, University of Poitiers and Consultant Endocrinologist and Diabetologist at Poitiers University Hospital, Poitiers, France

12:00 – 13:00 Poster Session 1 (PP1-8) - Aetiological Mechanisms

CHAIRS: DANIEL WITTE, RASMUS WIBAEK

P1 - BIOMARKERS OF SATURATED FATTY ACID AND INCIDENCE OF TYPE 2 DIABETES: A SYSTEMATIC REVIEW AND DOSE-RESPONSE META-ANALYSIS OF PROSPECTIVE OBSERVATIONAL STUDIES
Edyta Szczerba, German Diabetes Centre, Leibniz Centre for Diabetes Research at Heinrich Heine University Düsseldorf, Düsseldorf, Germany

P2 - THE ASSOCIATION BETWEEN CHRONIC STRESS AND VISCERAL OBESITY OVER 7 YEARS IN THE GENERAL POPULATION: THE HOORN STUDIES
Noreen Siddiqui, Amsterdam UMC, location VUmc, Amsterdam, the Netherlands

P3 - ADHERENCE TO A SUSTAINABLE DIET AND TYPE 2 DIABETES RISK – A DANISH COHORT STUDY
Fie Langmann. Department of Public Health, Aarhus University, Denmark

P4 - BODY MASS INDEX IN PARENTS AND THEIR ADULT OFFSPRING: A SYSTEMATIC REVIEW AND META-ANALYSIS
Jie Zhang, Department of Public Health, Aarhus University, Aarhus, Denmark

P5 - FASTING BLOOD GLUCOSE AMONG GHANAIAN ADULTS IS CAUSALLY LINKED WITH MALARIA PARASITE COUNT: A MECHANISTIC CASE STUDY USING CONVERGENT CROSS MAPPING
Carol A Abidha, Heidelberg Institute of Global Health, Universitätsklinikum Heidelberg, Heidelberg, Germany

P6 - THE ROLE OF PEDIATRIC BCG VACCINE IN TYPE 1 DIABETES ONSET
John Doupis, Salamis Naval and Veterans Hospital, Internal Medicine and Diabetes Department, Salamis, Greece

P7 - POSTPRANDIAL BIOACTIVITY OF SPREAD CHEESE ENHANCED WITH MOUNTAIN TEA AND ORANGE PEEL EXTRACT IN HEALTHY VOLUNTEERS: A CROSSOVER PILOT INTERVENTION STUDY
Olga Papagianni, Laboratory of Nutrition and Public Health, Food Science and Nutrition Department, University of the Aegean, Myrina Limnos, Greece

P8 - RISK FACTORS FOR TYPE 1 AND TYPE 2 DIABETES IN A SAMPLE OF THE GREEK ADULT POPULATION: REVIZITING THE BATTLEFIELD
Christina Voulgari, Fifth Department of Internal Medicine and Infectious Disease Unit, “Evaggelismos” Athens General Hospital, Athens, Greece

13:00 - 13:30 Lunch Break

13:30 - 14:20 Oral Presentations Session 3 - Quality of Life and Psychological Factors in Diabetes

CHAIRS: FEMKE RUTTERS, GREGERS STIG ANDERSEN

OP12 - THE ASSOCIATION BETWEEN NEIGHBORHOOD DRIVABILITY AND DIABETS INCIDENCE IN TORONTO
Nicole R den Braver, Amsterdam UMC, Amsterdam Public Health Research Institute, Amsterdam, The Netherlands

OP13, THE PREVALENCE OF INSOMNIA AND THE ASSOCIATION WITH METABOLIC OUTCOMES IN PEOPLE WITH TYPE 2 DIABETES: THE HOORN DIABETES CARE SYSTEM COHORT
Lenka Groeneveld, Amsterdam UMC, location VUmc, the Netherlands

OP14 - THE ASSOCIATION OF VITAL EXHAUSTION AND BURNOUT WITH (PARAMETERS OF) TYPE 2 DIABETES: A SYSTEMATIC REVIEW AND META-ANALYSIS Femke Rutters, Amsterdam UMC, Netherlands

OP15 - LIFESTYLE HABITS AND QUALITY OF LIFE IN ADULTS WITH TYPE 1 DIABETES: DIFFERENCES BY TYPE OF INSULIN REGIMEN
Melina Karipidou, Department of Nutrition and Dietetics, Harokopio University, Kallithea, Greece

OP16 - PREVALENCE OF ERECTILE DYSFUNCTION AMONG NOVEL DIABETES SUBGROUPS: RESULTS FROM THE GERMAN DIABETES STUDY
Maalmi Haifa, Institute for Clinical Diabetology, German Diabetes Center, Düsseldorf, Germany

14:20 - 14:25 5-min virtual exercise

14:25 - 15:15 Oral Presentations Session 4 - Complications of DM

CHAIRS: DORTE VISTISEN, PETER HARMS

OP17 - BODY MASS INDEX AND DIABETES MORTALITY: INSTRUMENTAL VARIABLE ANALYSIS USING OFFSPRING BMI AS INDICATOR OF OWN BMI
Kim Blond, Center for Clinical Research and Prevention, Bispebjerg and Frederiksberg Hospital, Copenhagen, Denmark

OP18 - EPIDEMIOLOGY OF COVID-19 IN PEOPLE WITH DIABETES IN NORWAY: A NATIONWIDE REGISTER BASED STUDY OF INFECTION, HOSPITALIZATION, VACCINATION AND MORTALITY
Paz Lopez-Doriga Ruiz, Department of Chronic Diseases and Ageing, Norwegian Institute of Public Health, Oslo, Norway

OP19 - Time trends in diabetes-related complications in France, in 2010-2019
Sandrine Fosse-Edorh, Santé publique France, Saint-Maurice, France

OP20 - "DIABETES MEDICATION USE IS ASSOCIATED WITH HIGHER GRADE AND INCREASED PROBABILITY OF MUSCLE-INVASIVE TUMOUR DISEASE IN PATIENTS WITH UROTHELIAL CARCINOMA "
Janine PM Faessen, Department of Clinical Epidemiology, VieCuri Medical Centre, Venlo, The Netherlands

OP21 - ASSOCIATION OF HBA1C WITH CANCER PROGNOSIS IN PEOPLE WITH DIABETES AND CANCER: A SYSTEMATIC REVIEW WITH META-ANALYSIS
Suping Ling, Department of Health Sciences, University of Leicester, UK

15:15 - 15:30 15 min break

15:30 - 16:30 Poster Session 2 (PP9-16) - Diabetes Monitoring and Treatment

CHAIRS: FRANCIS FINUCANE, FABIAN EICHELMANN

P9 - HETEROGENEITY IN TRAJECTORIES OF GLYCAEMIC CONTROL IN A LARGE COHORT OF CHILDREN AND ADOLESCENTS WITH TYPE-1-DIABETES
Rasmus Wibaek, Steno Diabetes Center Copenhagen, Gentofte, Denmark

P10 - ASSOCIATION BETWEEN SOCIAL JETLAG AND CHANGE IN GLYCEMIC CONTROL IN PEOPLE WITH TYPE 2 DIABETES. THE HOORN DIABETES CARE SYSTEM COHORT
Emma J Bouman, Amsterdam UMC, location VUmc, Amsterdam, the Netherlands

P11M - HEMOGLOBIN A1C LEVELS AMONG MIGRANTS WITH TYPE 2 DIABETES IN DENMARK: A CROSS-SECTIONAL ANALYSIS
Anders Aasted Isaksen, Aarhus University, Aarhus, Denmark

P12 - THE EFFECT OF SMOKING CESSATION ON METABOLIC PARAMETERS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
Stamatina Driva, 1st Department of Propaedeutic and Internal Medicine, Laiko General Hospital, National and Kapodistrian University of Athens, Athens, Greece

P13 - POLYPHARMACY IN PREGNANCY AND THE RISK OF CONGENITAL MALFORMATIONS – A SYSTEMATIC REVIEW
Mette Ø Thunbo, Department of Clinical Medicine, Aarhus University, Denmark

P14 - EVALUATION OF THE ACTIVITY OF MONOCYTES AND NEUTROPHILS IN PATIENTS WITH DIABETES AND SEPSIS
Kalliopi Lekka, Internal Medicine Department, University Hospital of Patras, Greece

P15 - STUDY OF THE PREVALENCE OF STRESS HYPERGLYCEMIA IN PEDIATRIC PATIENTS ADMITTED FOR ACUTE ILLNESS IN A TERTIARY CHILDREN’S HOSPITAL
Emmanouil Korakas, Second Department of Internal Medicine and Research Institute, Medical School, Attikon University Hospital, National and Kapodistrian University of Athens, Athens, Greece

P16 - CHALLENGES OF DESIGNING STUDY INTERVENTIONS, BASED ON ARTIFICIAL INTELLIGENCE, IN THE MANAGEMENT OF DIABETES MELLITUS: THE GATEKEEPER STUDY PROTOCOL FOR EVALUATION OF PREDICTIVE MODELLING OF GLYCAEMIC STATUS
George E. Dafoulas, University of Thessaly, Larisa, Greece

Tuesday 27th April 2021

09:00 - 09:50 Oral Presentations Session 5 - Type 1 Diabetes

CHAIRS: JEAN LAWRENCE, ELSE HELENE IBFELT

OP22 - TRAJECTORIES AND PREDICTORS OF HBA1C IN CHILDREN AND ADOLESCENTS WITH TYPE 1 DIABETES – A DANISH NATIONWIDE COHORT STUDY
Pernille F. Rønn, Steno Diabetes Center Copenhagen, Gentofte, Denmark

OP23 - SPATIO-TEMPORAL VARIATIONS IN THE INCIDENCE OF TYPE 1 DIABETES IN FRANCE IN CHILDREN UNDER 15 YEARS OLD
Clara Piffaretti, Santé publique France, Saint-Maurice, France

OP24 - MATERNAL GLUTEN INTAKE DURING PREGNANCY AND RISK OF ISLET AUTOIMMUNITY AND TYPE 1 DIABETES IN THE CHILD
Nicolai A Lund-Blix, Norwegian Institute of Public Health, Oslo, Norway

OP25 - PARENTAL EDUCATION OR OCCUPATION AND RISK OF CHILDHOOD TYPE 1 DIABETES
Lars C Stene, Norwegian Institute of Public Health, Oslo

OP26 - DIETARY FACTORS AND RISK OF ISLET AUTOIMMUNITY AND TYPE 1 DIABETES: A SYSTEMATIC REVIEW AND META-ANALYSIS
Anna-Maria Lampousi, Institute of Environmental Medicine, Karolinska Institutet, SE-171 77 Stockholm, Sweden

09:50 - 10:20 Plenary session 2 - Type 2 diabetes in the (frail) elderly

CHAIR: FEMKE RUTTERS

Petra Elders
Professor of General Practice, Department of General Practice and Elderly Care, Amsterdam UMC, University Medical Centers, The Netherlands

10:20 - 10:25 5-min virtual exercise

10:25 - 11:25 Poster Session 3 (PP17-24) - Diabetes Complications

CHAIRS: SARAH WILD, PERNILLE FALBERG RØNN

P17 - DISCONTINUATION OF CARDIOPROTECTIVE MEDICATION PRIOR TO DEATH, IN THE VERY ELDERLY: A NATIONWIDE REGISTER-BASED STUDY
Vanja Kosjerina, Steno Diabetes Center Copenhagen, Gentofte

P18 - SCREENING UPTAKE AND DETERMINANTS OF SCREENING FOR TYPE 2 DIABETES IN WOMEN WITH A HISTORY OF GESTATIONAL DIABETES: A RETROSPECTIVE COHORT STUDY
Elpida Vounzoulaki, Diabetes Research Centre, Leicester General Hospital, University of Leicester, Leicester, UK

P19 - ARTIFICIAL NEURONAL NETWORK MODEL FOR THREE- AND SIX-MONTH PROGNOSIS IN DIABETIC FOOT SYNDROME
Anna A Poradzka, Department of Diabetology and Internal Medicine, Medical University of Warsaw, Warsaw, Poland

P20 - DIABETES PREVALENCE AND HEALTH STATUS OF THE DIABETIC POPULATION IN MAYOTTE, FRANCE IN 2019
Abdullah Azaz, Santé publique France, Saint-Maurice, France

P21 - UNRAVELING THE CONCEPTS OF DISTRESS, BURNOUT, AND DEPRESSION IN TYPE 1 DIABETES: A SCOPING REVIEW
Dona A Kiriella, Community Health and Social Medicine Department, CUNY School of Medicine, New York, New York, United States

P22 - RETROSPECTIVE STUDY OF THE NEPHRO-METABOLIC PROTECTION FROM THE INTENSIFICATION OF TREATMENT WITH METFORMIN PLUS GLP-1 AGONISTS OR SGLT-2 INHIBITORS (STANDALONE OR IN COMBINATION): 24-MONTH REAL WORLD DATA.
Ioannis Zoupas, Mediterranean Diabetes and Obesity Clinics (MEDOC), Palaion Faliron, Attica and Karterados, Santorini, Greece

P23 - BURDEN OF DISEASE IN REFUGEE PATIENTS WITH DIABETES ON THE ISLAND OF LESVOS, GREECE
Nikolaos Bountouvis, Endocrinology and Diabetes Outpatient Clinics, General Hospital of Mytilini “Vostanio”, Lesvos, Greece

P24 - SCOUTING OF INDICATORS HELPING IN INVESTIGATING THE PATHOGENESIS OF DIABETIC ANGIOPATHY AND NEPHROPATHY IN DIABETES MELLITUS TYPE 1
Olga Ellina, General Hospital of Nea Ionia

11:25 - 11:50 15 min break

11:50 - 12:40 Oral Presentations Session 6 - CVD

CHAIRS: KONSTANTINOS MAKRILAKIS, HANAN AMADID

OP27 - ASSOCIATION OF ECG ABNORMALITIES WITH MAJOR ADVERSE CARDIAC EVENTS IN PEOPLE WITH TYPE 2 DIABETES: THE HOORN DIABETES CARE SYSTEM COHORT
Peter P Harms, Amsterdam University Medical Centers, Amsterdam, the Netherlands

OP28 - INCIDENCE OF MICRO- AND MACROVASCULAR COMPLICATIONS AMONG PERSONS WITH TYPE 2 DIABETES WITH AND WITHOUT SEVERE MENTAL ILLNESS. A NATIONWIDE STUDY
Stine H Scheuer, Steno Diabetes Center (SDC) Copenhagen, Denmark

OP29 - TRIMETHYLAMINE N-OXIDE IS ASSOCIATED WITH INCREASED RISK OF CARDIOVASCULAR MORTALITY IN TYPE 2 DIABETES: RESULTS FROM A DUTCH PROSPECTIVE COHORT
Jose L. Flores-Guerrero, Department of Internal Medicine, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands

OP30 - DETERIORATION OF AUTONOMIC NERVOUS FUNCTION IS ASSOCIATED WITH THE DEVELOPMENT OF ARTERIAL STIFFNESS: THE WHITEHALL II COHORT
Jonas Frey Rosborg Schaarup, Aarhus University, Aarhus, Denmark; Steno Diabetes Centre Aarhus, Aarhus University Hospital, Denmark

OP31 - THE PREVALENCE AND CARDIOVASCULAR RISK PROFILE OF UNDIAGNOSED DIABETES IN A NORWEGIAN POPULATION. THE HUNT4 SURVEY
Vera Vik Bjarkø, Norwegian University of Science and Technology, University in Trondheim, Norway

12:40 - 13:30 General Assembly (EDEG Members only)


You can download the Scientific Program HERE